4th Quarter - Amendment

GREENBERG TRAURIG, LLP for INTREXON CORPORATION

Firm
Client
Income
$230,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 24, 2017 $230,000 Replaced
4th Quarter - Amendment (this page) Mar 23, 2017 $230,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitor legislative and administrative action related to response to the Zika virus and outreach regarding same. H.R. 2028, Further Continuing and Security Assistance Appropriations Act, 2017 (PL 114-254). H.R. 2029, Consolidated Appropriations Act, 2016 PL (114-113). H.R. 2577, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017. H.R. 3020, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (PL 114-195). H.R. 3299, Strengthening Public Health Emergency Response Act of 2015. H.R. 5044, Making supplemental appropriations for fiscal year 2016 to respond to Zika virus. H.R. 5243, Zika Response Appropriations Act, 2016 H.R. 5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act (PL 114-223). S. 1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (PL 114-195). S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. S.2609 - An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. S. 2843, A bill to provide emergency supplemental appropriations to address the Zika crisis. S. 2899, Zika Response and Regulatory Relief Act. S. 3117, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017 Monitor Administrative Action on Experimental Use Permits for Walbachia Pipientis wAlB strain (EPA- HQ -2015 - 0374).

Foreign entity interest: Oxitec Ltd. 71 Innovation Dr. Milton Park Abingdon, UK

LobbyistCovered position, as disclosed
DIANE J BLAGMAN New Chief of Staff, Rep. Bob Carr; Associate Staff, House Appropriations Committee
HAYDEN R DEMPSEY —
TIM HUTCHINSON —
JULIANA LAURELLO —
ROBERT MANGAS —
GRAHAM MATHEWS —
JOE R REEDER —
ALBERT WYNN —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Environmental Protection Agency (EPA)

Bills named: H.R. 5325 (114th), H.R. 3299 (114th), H.R. 5044 (114th), H.R. 2577 (114th), S. 1695 (114th), H.R. 5243 (114th), S. 2899 (114th), H.R. 2028 (114th), S. 2843 (114th), S. 2512 (114th), S. 3117 (114th), H.R. 3020 (114th), H.R. 2029 (114th), S. 2609 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.